|
David,
The primary use of Promacta (a brand name for eltrombopag) is to boost platelets, and it's benefited many patients. But if anemia (low HGB) is your primary concern, then among available drug treatments I'd expect an erythropoiesis-stimulating agent (ESA) to be a more likely recommendation from your hematologist.
ESAs include Aranesp (a brand name for darbepoetin alfa), Epogen (a brand name for epoetin alfa), and Procrit (a brand name for epoetin alfa).
In my layperson's opinion, wait and watch is still a reasonable approach to take, even though slightly low HGB doesn't give you the stamina you've previously had. It may not be worth risking the side effects of an ESA or other drug to try to increase your red blood cell count, when it's currently "low but livable."
Many people live with low counts by making small adjustments in their lifestyle: a little less strenuous activity, taking care of your diet, exercise, and sleep, avoiding activities likely to lead to bumps and bruises, etc. If you stick with watch-and-wait, and your counts drop into a range of more concern, you and your hematologist may then lean more toward starting a drug treatment.
__________________
Founder of Marrowforums and caregiver for my wife
|